J. Domagala-Kulawik (Warsaw, Poland), T. Maher (London, United Kingdom), A. Morais (Maia, Portugal)
Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
P. Upadhya, V. S. Kumar, M. K. Panigrahi, N. Veer Singh (Pondicherry, Bhuvaneshwar, India)
|   |
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
T. Tsuji, T. Arai, M. Hirose, C. Sugimoto, K. Tachibana, M. Akira, M. Kitaichi, S. Hayashi, Y. Inoue (Osaka, Japan)
| |
Interstitial lung disease in the connective tisssue disease
S. Aouadi, A. Sebai, H. Gharsalli, H. Snene, N. Ghrairi, S. Maalej, L. El Gharbi (Tunis, Tunisia)
| |
Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients
A. Zamora, D. White, A. M. Sykes, J. Yi, J. Ryu (Rochester, United States Of America)
| |
Microscopic polyangiitis: Type of interstitial pneumonitis on chest HRCT and the clinical features
W. Zhao, H. Dai, Y. Liu, C. Wang (Beijing, China)
| |
The prognostic factor in patients with myositis-associated interstitial lung disease
A. Shiraki, M. Ando, T. Abe, H. Nakashima, M. Hibi, J. Shindo (Ogaki, Japan)
| |
Clinical features of microscopic polyangiitis with usual interstitial pneumonia-like fibrosis in comparison with idiopathic pulmonary fibrosis
W. Zhao, H. Dai, Y. Liu, C. Wang (Beijing, China)
| |
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
T. Hamada, T. Samukawa, T. Kumamoto, I. Higashimoto, K. Mizuno, M. Watanabe, H. Inoue (Kagoshima, Japan)
| |
Evaluation of lung lesions in LATY136F mutant mice ∼Are they recognized as the models of IgG4 related lung disease?∼
Y. Waseda, S. Matsui, K. Yamada, S. Watanabe, R. Matsunuma, H. Takato, M. Kawano, M. Yasui, K. Kasahara (Kanazawa, Toyama, Komatsu, Japan)
| |
"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
S. Sharma, W. Banya, E. Renzoni, A. Wells, M. Toby (London, United Kingdom)
| |
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
T. Niwa, H. Tachibana, M. Arita, T. Ishida, T. Takaiwa, K. Furuta, M. Tanaka, F. Tokioka, T. Hashimoto (Hashima-Gun, Kurashiki, Japan)
| |
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
T. Nakaya, M. Bando, M. Nakayama, N. Mato, H. Yamasawa, Y. Sugiyama (Shimotsuke, Japan)
| |
Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis
C. Hosoda, T. Baba, H. Kitamura, E. Hagiwara, T. Iwasawa, N. Yanagawa, F. Sakai, K. Okudela, T. Takemura, T. Ogura (Yokohama, Tokyo, Saitama, Japan)
| |
The clinical features of 13 patients with interstitial pneumonia with positive anti-glycyl-tRNA synthetase autoantibodies
H. Sasano, H. Kitamura, T. Baba, Y. Enomoto, N. Matsuo, E. Hagiwara, M. Nakagawa, E. Iwata, K. Okudera, S. Sato, Y. Suzuki, T. Iwasawa, T. Takemura, T. Ogura (Yokohama, Shibuya, Isehara, Japan)
| |
Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion
B. Oehrle, G. Burgstaller, M. Irmler, S. Dehmel, A. Cornett, T. Hwang, J. Beckers, S. Krauss-Etschmann, E. S. White, S. Meiners, O. Eickelberg (Munich, Germany; Ann Arbor, United States Of America)
| |
IL-17+ cells immunoexpression in systemic sclerosis pulmonary fibrosis
A. P. Pereira Velosa, M. Abdo Paiva, P. Cristina Andrade, R. B. Christmann, E. Miristeni Eher, S. Morais Fernezlian, E. Roger Parra, W. Rosolia Teodoro, V. L. Capelozzi (Sao Paulo, Brazil)
| |
Collagen V overexpression correlates with IL-17+ cells in C57BL/6 mice pulmonary remodeling
P. C. Andrade, A. P. Pereira Velosa, A. dos Santos Filho, S. de Morais, E. Miristeni Eher, S. Catanozi, V. L. Capelozzi, W. Rosolia Teodoro (Sao Paulo, Brazil)
| |
Type V collagen induced pulmonary fibrosis in C57Bl/6mice
W. Rosolia Teodoro, A. P. Pereira Velosa, A. dos Santos Filho, P. C. Andrade, V. Martins, S. Morais Fernezlian, S. Catanozi, V. L. Capelozzi (Sao Paulo, Brazil)
| |
Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement
M. Yousif, R. Habib, H. Esaely, R. Yasin, A. Sonbol (Shebin Elkom, Egypt)
| |
Elevation of serum napsin A in interstitial lung diseases in comparison with KL-6 and surfactant protein-D
T. Samukawa, T. Hamada, T. Kumamoto, M. Watanabe, K. Mizuno, I. Higashimoto, H. Inoue (Kagoshima, Japan)
| |